{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:44:22Z","timestamp":1762598662341,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302432"],"award-info":[{"award-number":["82302432"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["201803040004","202201011027"],"award-info":[{"award-number":["201803040004","202201011027"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virus Eradication"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jve.2025.100595","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:42:23Z","timestamp":1742949743000},"page":"100595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-level adenovirus-neutralizing antibodies plasma beneficial for adenovirus type 7 (Adv7) induced pediatric severe ARDS"],"prefix":"10.1016","volume":"11","author":[{"given":"Feiyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinda","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jve.2025.100595_bib1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12879-015-1126-2","article-title":"Adenovirus infection in children with acute lower respiratory tract infections in Beijing, China, 2007 to 2012","volume":"15","author":"Liu","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jve.2025.100595_bib2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/apa.12689","article-title":"Postinfectious bronchiolitis obliterans in children: the South American contribution","volume":"103","author":"Castro-Rodriguez","year":"2014","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jve.2025.100595_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2431-14-238","article-title":"Post-infectious bronchiolitis obliterans in children: a review of 42 cases","volume":"14","author":"Li","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jve.2025.100595_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jmv.25333","article-title":"Epidemiology of human adenovirus infection in children hospitalized with lower respiratory tract infections in Hunan, China","volume":"91","author":"Xie","year":"2019","journal-title":"J Med Virol"},{"key":"10.1016\/j.jve.2025.100595_bib5","article-title":"Postinfectious bronchiolitis obliterans in children: diagnostic workup and therapeutic options: a workshop report","volume":"2020","author":"Jerkic","year":"2020","journal-title":"Can Respir J"},{"key":"10.1016\/j.jve.2025.100595_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0885066616681272","article-title":"Treatment of adenoviral acute respiratory distress syndrome using cidofovir with extracorporeal membrane oxygenation","volume":"32","author":"Lee","year":"2017","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jve.2025.100595_bib7","doi-asserted-by":"crossref","first-page":"758","DOI":"10.12688\/f1000research.8374.2","article-title":"Use of cidofovir in pediatric patients with adenovirus infection","volume":"5","author":"Ganapathi","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.jve.2025.100595_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fped.2020.00162","article-title":"Severe adenovirus pneumonia requiring extracorporeal membrane oxygenation support in immunocompetent children","volume":"8","author":"Chen","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jve.2025.100595_bib9","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.rmed.2013.09.008","article-title":"Severe adenovirus pneumonia requiring extracorporeal membrane oxygenation support--Serotype 7 revisited","volume":"107","author":"Low","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jve.2025.100595_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3851\/IMP3243","article-title":"Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience","volume":"23","author":"Ko","year":"2018","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jve.2025.100595_bib11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12879-015-1169-4","article-title":"Ebola virus disease complicated with viral interstitial pneumonia: a case report","volume":"15","author":"Petrosillo","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jve.2025.100595_bib12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-2600(17)30174-1","article-title":"Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study","volume":"5","author":"Beigel","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jve.2025.100595_bib13","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jve.2025.100595_bib14","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1172\/JCI138759","article-title":"Kinetics of viral load and antibody response in relation to COVID-19 severity","volume":"130","author":"Wang","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jve.2025.100595_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/104303404322886147","article-title":"Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines","volume":"15","author":"Aste-Amezaga","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jve.2025.100595_bib16","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.3389\/fmicb.2018.03040","article-title":"Seroprevalence of neutralizing antibodies to human adenovirus type 4 and 7 in healthy populations from southern China","volume":"9","author":"Ye","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jve.2025.100595_bib17","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1038\/emi.2017.29","article-title":"Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China","volume":"6","author":"Zheng","year":"2017","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jve.2025.100595_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1743-422X-9-287","article-title":"A serological survey of human adenovirus serotype 2 and 5 circulating pediatric populations in Changchun, China, 2011","volume":"9","author":"Yu","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.jve.2025.100595_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217524","article-title":"Disseminated adenovirus infection causing severe ARDS","volume":"2017","author":"Campbell","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jve.2025.100595_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/srep37216","article-title":"Fatal community-acquired pneumonia in children caused by Re-emergent human adenovirus 7d associated with higher severity of illness and fatality rate","volume":"6","author":"Yu","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jve.2025.100595_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12887-022-03225-1","article-title":"Mortality reduction in pediatric patients with severe fatal human adenoviral pneumonia treated with high titer neutralizing antibodies (NAbs) plasma: a retrospective cohort study","volume":"22","author":"Peng","year":"2022","journal-title":"BMC Pediatr"},{"issue":"2","key":"10.1016\/j.jve.2025.100595_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/PCC.0000000000003147","volume":"24","author":"Emeriaud","year":"2023","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"10.1016\/j.jve.2025.100595_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01751-22","article-title":"Outcomes of convalescent plasma with defined high versus lower neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus inactivating plasma (CoVIP) study","volume":"13","author":"Bartelt","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.jve.2025.100595_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fped.2019.00265","article-title":"Lung microbiota and pulmonary inflammatory cytokines expression vary in children with tracheomalacia and adenoviral or mycoplasma pneumoniae pneumonia","volume":"7","author":"Wang","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jve.2025.100595_bib25","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.12659\/MSM.910692","article-title":"Serum inflammatory markers in patients with adenovirus respiratory infection","volume":"24","author":"Sun","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jve.2025.100595_bib26","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1099\/vir.0.017905-0","article-title":"Human lung innate immune cytokine response to adenovirus type 7","volume":"91","author":"Wu","year":"2010","journal-title":"J Gen Virol"}],"container-title":["Journal of Virus Eradication"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664025000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664025000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:41:53Z","timestamp":1762598513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2055664025000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2055664025000147"],"URL":"https:\/\/doi.org\/10.1016\/j.jve.2025.100595","relation":{},"ISSN":["2055-6640"],"issn-type":[{"type":"print","value":"2055-6640"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-level adenovirus-neutralizing antibodies plasma beneficial for adenovirus type 7 (Adv7) induced pediatric severe ARDS","name":"articletitle","label":"Article Title"},{"value":"Journal of Virus Eradication","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jve.2025.100595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100595"}}